These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 5623600)
41. [Treatment of decompensated cor pulmonale with heptaminol theophyllineacetate]. John P Munch Med Wochenschr; 1972 Jul; 114(27):1253-6. PubMed ID: 5068592 [No Abstract] [Full Text] [Related]
42. [Clinical experience with a new diuretic: ethacrynic acid]. Linquette M; Fossati P; Lefebvre J Lille Med; 1968 Oct; ():Suppl 6:831-5. PubMed ID: 5748103 [No Abstract] [Full Text] [Related]
43. [Oral sotbitol in treatment of refractory cardiac edema]. Fischetti F Clin Ter; 1971 Nov; 59(3):207-12. PubMed ID: 5160467 [No Abstract] [Full Text] [Related]
44. [Relations between cardiac insufficiency and stomach--a critical contribution on the conception of so-called congestive gastritis]. Bohm R; Günther KH; David H; Theuer D; Günther H Dtsch Gesundheitsw; 1969 Jan; 24(4):165-8. PubMed ID: 5386436 [No Abstract] [Full Text] [Related]
45. Acute effects of oral ethacrynic acid upon total blood volume. Samet P; Bernstein WH Am Heart J; 1968 Mar; 75(3):288-90. PubMed ID: 5638467 [No Abstract] [Full Text] [Related]
46. Mode of action of ethacrynic acid in congestive heart failure. Porter GA; Bennett WH; Griswold HE Arch Intern Med; 1968 Mar; 121(3):235-42. PubMed ID: 5642743 [No Abstract] [Full Text] [Related]
47. Treatment of heart disease. Hill SI Practitioner; 1980 Jun; 224(1344):633-36. PubMed ID: 6999488 [No Abstract] [Full Text] [Related]
48. [Unfavourable cardiovascular effects of propranolol]. Lega P; Milazzotto F Clin Ter; 1968 Jun; 45(5):461-8. PubMed ID: 5737086 [No Abstract] [Full Text] [Related]
52. [Use of ethacrynic acid in the surgical clinical aspects of patients with rheumatic heart diseases and circulatory insufficiency]. Malinovskiĭ NN; Golubev IS; Tarichko IuV Sov Med; 1971 Apr; 34(4):118-22. PubMed ID: 5143737 [No Abstract] [Full Text] [Related]
53. [Direct positive inotropic influencing on the heart using oral spironolactone therapy]. Schröder R; Ramdohr B; Hüttemann U; von Leitner E; Schüren KP Verh Dtsch Ges Kreislaufforsch; 1972; 38():349-53. PubMed ID: 4576732 [No Abstract] [Full Text] [Related]
54. [Clinical trial of a new cardiac glycoside: cd.412]. Gentile C; Gentile JH Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118 [No Abstract] [Full Text] [Related]
55. [Clinical experience with the use of a new drug: "ethacrynic acid"]. Cicconetti C; Cantera N Policlinico Prat; 1969 Jan; 76(3):69-78. PubMed ID: 5763598 [No Abstract] [Full Text] [Related]
56. [On the clinical use of proscillaridin A (Sandoscill)]. Straube W Med Welt; 1967 Sep; 39():2312-4. PubMed ID: 5629431 [No Abstract] [Full Text] [Related]
57. [Treatment of severe cardiac insufficiency with endovenous nitroglycerin]. Coma Canella I; López-Sendón JL; Benito F; Lacort M Rev Esp Cardiol; 1981; 34(1):63-71. PubMed ID: 6792665 [No Abstract] [Full Text] [Related]
58. [Experimental and clinical viewpoints on the effect of digitalis]. Hochrein H Munch Med Wochenschr; 1969 Jun; 111(23):1294-300. PubMed ID: 5820132 [No Abstract] [Full Text] [Related]